Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-078 manufacturers

Filters

Filters

Filters , active

Country of origin : Japan

Clear all

None products found

pp-078

Injection

Dossier type
CTD
Dossier status
Under development
Country of origin
Japan
GMP approvals
Japan
Comments
Indication: Vocal cord scarring (vocal fold fibrosis) causing impaired phonation and reduced vocal function. Clinical stage: Phase I/II open-label dose-escalation investigator-initiated trial completed; Phase III multicenter, randomized, placebo-controlled, double-blind comparative trial ongoing. Mechanism / Target: the c-MET receptor activation to promote antifibrotic activity, tissue repair, and regeneration within the vocal fold lamina propria, aiming to restore pliability and vocal fold vibration. Route / form: Local intracordal injection into the vocal fold, as used in clinical studies. Differentiation: First-in-class regenerative biologic directly targeting fibrosis and restoring vocal function; demonstrated safety and biological activity in early trials and is advancing through pivotal evaluation.
Manufacturer #38606

A clinical-stage biopharmaceutical firm pioneering regenerative medicines based on a human growth factor protein. It develops therapies for intractable and rare diseases — including spinal-cord injury, organ damage, and tissue scarring — with global development and commercialization ambitions.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.